Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）

2019-12-19 欧洲皮肤病学论坛 Eur J Cancer. 2019 Dec 19.

:黑色素瘤

2019年12月，由欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)组成的多学科专家小组共同发布了黑色素瘤的治疗指南，主要内容涉及皮肤黑色素瘤的诊断和管理。

中文标题：

2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）

英文标题：

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.

发布机构：

欧洲皮肤病学论坛

发布日期：

2019-12-19

简要介绍：

2019年12月，由欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)组成的多学科专家小组共同发布了黑色素瘤的治疗指南，主要内容涉及皮肤黑色素瘤的诊断和管理。

 

拓展指南：与黑色素瘤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）)] GetToolGuiderByIdResponse(projectId=1, id=722571c001859068, title=2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）, enTitle=European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019., guiderFrom=Eur J Cancer. 2019 Dec 19., authorId=null, author=, summary=2019年12月，由欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)组成的多学科专家小组共同发布了黑色素瘤的治疗指南，主要内容涉及皮肤黑色素瘤的诊断和管理。 , cover=, journalId=null, articlesId=null, associationId=450, associationName=欧洲皮肤病学论坛, associationIntro=The practice of dermatology has, over the past 30 years, been distinguished by its transition from provision of essentially empirical treatments to a practice in which rational therapies, based on enhanced knowledge of the pathogenesis of disease, are administered. Coincidentally, the boundaries between organ specific specialities such as our own have become blurred. Thus there is now great overlap with numerous other medical disciplines. These include: oncology, immunology / allergology, plastic surgery, oral medicine and, increasingly rheumatology and other disciplines in which management of chronic inflammatory disease plays an important role., copyright=0, guiderPublishedTime=Thu Dec 19 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年12月，由欧洲皮肤病学论坛(EDF)、欧洲皮肤肿瘤协会(EADO)和欧洲癌症治疗研究组织(EORTC)组成的多学科专家小组共同发布了黑色素瘤的治疗指南，主要内容涉及皮肤黑色素瘤的诊断和管理。 </P> <P> </P>拓展指南：<strong>与<font color=red>黑色素瘤</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=ff70e1c001852ef2" title="2019 欧洲多学科共识指南：黑色素瘤的诊断" target=_blank>2019 欧洲多学科共识指南：黑色素瘤的诊断</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e77a91c0018362d1" title="2019 JDA指南：皮肤黑色素瘤（概述）" target=_blank>2019 JDA指南：皮肤黑色素瘤（概述）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1ddc61c00183262e" title="NCCN临床实践指南：皮肤黑色素瘤（2019.V3）" target=_blank>NCCN临床实践指南：皮肤黑色素瘤（2019.V3）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=4c4cc1c001e9594b" title="皮肤黑色素瘤的主要切除切缘，前哨淋巴结活检和完全淋巴结清扫：临床实践指南" target=_blank>皮肤黑色素瘤的主要切除切缘，前哨淋巴结活检和完全淋巴结清扫：临床实践指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a50881c001e9021f" title="2018 英国共识声明：前哨淋巴结活检在皮肤黑色素瘤管理中的作用" target=_blank>2018 英国共识声明：前哨淋巴结活检在皮肤黑色素瘤管理中的作用</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E9%BB%91%E8%89%B2%E7%B4%A0%E7%98%A4" target=_blank>有关黑色素瘤更多指南</a></ul>, tagList=[TagDto(tagId=70530, tagName=:), TagDto(tagId=273, tagName=黑色素瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8115, appHits=219, showAppHits=20, pcHits=3677, showPcHits=5483, likes=43, shares=11, comments=5, approvalStatus=1, publishedTime=Thu Jan 30 02:37:55 CST 2020, publishedTimeString=2019-12-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jan 30 02:37:55 CST 2020, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 14:37:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）)])
2019 欧洲多学科共识指南：黑色素瘤的治疗（更新版）
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1071380, encodeId=177d10e138041, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f5719749, createdName=ms8000001197684057, createdTime=Thu Nov 18 12:17:30 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883172, encodeId=ddb38831e27a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/f0fd4edbc73e4a3bb55ba748c002f51a/5bc7ce71ddc34e23947febcbe9bcaecd.jpg, createdBy=2a215316349, createdName=1489b237m71暂无昵称, createdTime=Sun Sep 06 22:29:27 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379304, encodeId=d9963e9304bf, content=没有中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJq5N0DcbPjdDjh2Lq0Hl1usA7mdTRiaQ1QicG1slggV0u2nbEoWVNsUxITUsUle6vhKuz0xjwpSxYQ/132, createdBy=dc322371199, createdName=乐乐鱼, createdTime=Sun Feb 16 10:20:20 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378736, encodeId=c62a3e87367e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Fri Jan 31 07:32:48 CST 2020, time=2020-01-31, status=1, ipAttribution=)]
    2021-11-18 ms8000001197684057

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1071380, encodeId=177d10e138041, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f5719749, createdName=ms8000001197684057, createdTime=Thu Nov 18 12:17:30 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883172, encodeId=ddb38831e27a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/f0fd4edbc73e4a3bb55ba748c002f51a/5bc7ce71ddc34e23947febcbe9bcaecd.jpg, createdBy=2a215316349, createdName=1489b237m71暂无昵称, createdTime=Sun Sep 06 22:29:27 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379304, encodeId=d9963e9304bf, content=没有中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJq5N0DcbPjdDjh2Lq0Hl1usA7mdTRiaQ1QicG1slggV0u2nbEoWVNsUxITUsUle6vhKuz0xjwpSxYQ/132, createdBy=dc322371199, createdName=乐乐鱼, createdTime=Sun Feb 16 10:20:20 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378736, encodeId=c62a3e87367e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Fri Jan 31 07:32:48 CST 2020, time=2020-01-31, status=1, ipAttribution=)]
    2020-09-06 1489b237m71暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1071380, encodeId=177d10e138041, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f5719749, createdName=ms8000001197684057, createdTime=Thu Nov 18 12:17:30 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883172, encodeId=ddb38831e27a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/f0fd4edbc73e4a3bb55ba748c002f51a/5bc7ce71ddc34e23947febcbe9bcaecd.jpg, createdBy=2a215316349, createdName=1489b237m71暂无昵称, createdTime=Sun Sep 06 22:29:27 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379304, encodeId=d9963e9304bf, content=没有中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJq5N0DcbPjdDjh2Lq0Hl1usA7mdTRiaQ1QicG1slggV0u2nbEoWVNsUxITUsUle6vhKuz0xjwpSxYQ/132, createdBy=dc322371199, createdName=乐乐鱼, createdTime=Sun Feb 16 10:20:20 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378736, encodeId=c62a3e87367e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Fri Jan 31 07:32:48 CST 2020, time=2020-01-31, status=1, ipAttribution=)]
    2020-02-16 乐乐鱼

    没有中文版？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1071380, encodeId=177d10e138041, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f5719749, createdName=ms8000001197684057, createdTime=Thu Nov 18 12:17:30 CST 2021, time=2021-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883172, encodeId=ddb38831e27a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200908/f0fd4edbc73e4a3bb55ba748c002f51a/5bc7ce71ddc34e23947febcbe9bcaecd.jpg, createdBy=2a215316349, createdName=1489b237m71暂无昵称, createdTime=Sun Sep 06 22:29:27 CST 2020, time=2020-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=379304, encodeId=d9963e9304bf, content=没有中文版？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJq5N0DcbPjdDjh2Lq0Hl1usA7mdTRiaQ1QicG1slggV0u2nbEoWVNsUxITUsUle6vhKuz0xjwpSxYQ/132, createdBy=dc322371199, createdName=乐乐鱼, createdTime=Sun Feb 16 10:20:20 CST 2020, time=2020-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378736, encodeId=c62a3e87367e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Fri Jan 31 07:32:48 CST 2020, time=2020-01-31, status=1, ipAttribution=)]
    2020-01-31 thm112988

    好

    0

相关指南

2020 ESICM临床实践指南：非出血性重症患者的输血策略

欧洲危重病医学会(ESICM,European Society of Intensive Care Medicine) · 2020-01-07

2020 EHS/AHS指南：脐疝和上腹疝的治疗

欧洲疝学会(EHS,the European Hernia Society) · 2020-01-09

2019 多学科共识文件：转移性激素敏感和转移性去势抵抗性前列腺癌患者的监测

国外肿瘤科相关专家小组（统称） · 2019-12-01

2019 SIA意见书：晚期酒精性肝病和重症急性酒精性肝炎的管理

意大利酒精协会 · 2019-11-19

2019 意大利共识建议：轻度认知功能障碍基于生物标志物的病因诊断

国外神经内科相关专家小组（统称） · 2019-11-06

2019 EHRA国际共识：心脏植入性电子设备感染的预防，诊断和治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2019-11-08

Baidu
map
Baidu
map
Baidu
map